Concepedia

Istradefylline as monotherapy for Parkinson disease: Results of the 6002-US-051 trial

Hubert H. Fernandez, David Greeley, Richard M. Zweig, Joanne Wojcieszek, Akihisa Mori, N. M. Sussman

Parkinsonism & Related Disorders · 2009 · 116 citations · 11 references

DOI

Concepts

References

11

Recent Developments in Parkinson's Disease

Howard I. Hurtig · Neurology · 1987 · 1.9K citations

, , +12

Differential behavioral effects in frontal lobe disease

Arthur L. Benton · Neuropsychologia · 1968 · 1.4K citations

, , +13

Adenosine A<sub>2A</sub> Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys

Tomoyuki Kanda, Michael Jackson, Lance A. Smith et al. · Annals of Neurology · 1998 · 356 citations

, , +16

Adenosine A <sub>2A</sub> receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)

Peter A. LeWitt, Mark Guttman, James W. Tetrud et al. · Annals of Neurology · 2008 · 350 citations

, , +13

Adenosine A <sub>2A</sub> receptor antagonist treatment of Parkinson’s disease

William Bara‐Jimenez, Ayesha Sherzai, Tzvetelina Dimitrova et al. · Neurology · 2003 · 327 citations

, , +17